Innovative Tech Focus Qubigen leverages advanced AI and federated data technologies to drive drug discovery, presenting opportunities for collaboration with pharmaceutical and biotech companies seeking cutting-edge computational solutions.
Strategic Industry Engagement Active participation in major biotech events like JPM Week and BIO conferences indicates Qubigen’s openness to partnerships and investor interest, creating avenues for targeted outreach to establish strategic alliances.
Recent Collaborations Partnerships with Rio Pharmaceuticals, GigCity, and the University of Adelaide suggest Qubigen is expanding its network within the biotech and government innovation sectors, offering potential joint development and data-sharing opportunities.
Growth Funding and Revenue With over $2.2 million in funding and estimated revenue under $1 million, Qubigen is in a growth phase, making it a compelling target for investors and service providers offering solutions to scale AI-driven drug discovery efforts.
Market Positioning Positioned in the AI biotech sector with a focus on rare and oncogenic cancers, Qubigen offers a specialized niche for companies providing bioscience data, AI tools, or clinical trial collaborations aimed at precision medicine applications.
Presagen uses 8 technology products and services including Google Cloud CDN, Webpack, Wix eCommerce, and more. Explore Presagen's tech stack below.
| Presagen Email Formats | Percentage |
| First@presagen.com | 67% |
| First.Last@presagen.com | 13% |
| FirstLast@presagen.com | 13% |
| FirLast@presagen.com | 7% |
Hospitals and Health CareCalifornia, United States2-10 Employees
Presagen has merged with Qubist to become Qubigen. Qubigen is an exciting new venture that merges Presagen’s Federated AI technology and Qubist’s virtual screening and AI drug design capability. Qubigen’s mission is to create the largest global federated proprietary dataset and computational toolbox for AI driven drug design. Visit Qubigen at: https://www.qubigen.com.
Company Overview
Funding & FinancialsPresagen has raised a total of $2.2M of funding over 3 rounds. Their latest funding round was raised on Aug 01, 2021 in the amount of $2.2M.
Presagen's revenue is estimated to be in the range of $1M
Funding & FinancialsPresagen has raised a total of $2.2M of funding over 3 rounds. Their latest funding round was raised on Aug 01, 2021 in the amount of $2.2M.
Presagen's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com